Products and methods associated with multiple sclerosis as a transmissible protein misfolding disorder
AssigneeAmira Medical Technologies Inc.
InventorsPeter Stys, Gerald W. Zamponi, Shigeki Tsutsui
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmira Medical Technologies Inc.
InventorsPeter Stys, Gerald W. Zamponi, Shigeki Tsutsui
Estimating the term…
Described are methods and products related to the identification of multiple sclerosis (MS) as a transmissible protein misfolding disorder. Data is presented to support the position that the transmissible protein is an abnormal prion protein conformer (PrPMS). Methods are described for identifying a subject having, or at risk of developing, multiple sclerosis (MS) based on determining the presence or absence of PrPMS in a sample from the subject. The presence of the abnormal prion protein conformer in the sample is indicative of the subject having MS or an increased risk of developing MS. Also described are therapeutics methods for the treatment of MS as well as cell cultures, non-human animal models and biological samples thereof useful for the study of MS.
A method of identifying a subject having, or at risk of developing, multiple sclerosis (MS), the method comprising:
-10. (canceled)
-13. (canceled)
-17. (canceled)
-39. (canceled)
A non-human animal model of multiple sclerosis (MS), produced by administering abnormal prion protein conformer (PrPMS) to a non-human animal, wherein PrPMS is a transmissible, proteinase K-sensitive conformer of PrP.
(canceled)
(canceled)
-52. (canceled)
(canceled)
-73. (canceled)
A method of producing a non-human animal model of multiple sclerosis (MS), the method comprising administering abnormal prion protein conformer (PrPMS) to the non-human animal, wherein PrPMS is a transmissible, proteinase K-sensitive conformer of PrP, wherein the non-human animal develops one or more signs or symptoms of MS after administration of PrPMS.
Dependencies are inferred from the claim text.